Funding the Future: unlocking capital to power the growth we need
12:00 am - 1:00 pmCompany overview
genedrive® provides a rapid and low cost molecular diagnostics platform for the identification and treatment selection of infectious diseases, human genotyping, animal health, pathogen identification, and other applications.
genedrive has also developed the first portable device to diagnose the Hepatitis C virus.
Website
genedriveplc.comCompany information
Head office
- Manchester
CEO
- David Budd
Chair
BGF office
BGF team
Investment date
- Dec 2018
Total BGF investment
- £3.5 million